Reduction of thrombotic and hemorrhagic complications after stent implantation

American Heart Journal

Volumn 132, Issue 6, 1996, Pages 1119-1126

  Pan, Manuel ^a   De Lezo, José Suárez ^a   Velasco, Francisco ^a   Romero, Miguel ^a   Medina, Alfonso ^b   Segura, José ^a   Hernández, Enrique ^b   Pavlovic, Djordje ^a   Melian, Francisco ^b   Gallardo, Arsenio ^a   Zayas, Ricardo ^a   Ruiz, Martin ^a   Torres, Antonio ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Hospital del Pino

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL PROTOCOL; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STENT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOGENICITY;

EID: 12644262393     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90454-8     Document Type: Article

References (29)

1. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of multicenter study. Circulation 1991;83:148-61.
2. Serruys PW, Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al., for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
3. Fischman DL, León MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparision of coronary-stent placement and ballon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
4. Herrmann HC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon MB, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-9.
5. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
6. Diaz L, Fajadet J, Cassagneau, Robert G, Marco J. Early outcome and angiographic predictors of subacute closure in Palmaz-Schatz coronary stenting. Rev Esp Cardiol 1994;47:747-53.
7. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 1994;24:996-1003.
8. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, et al. Intracoronary ultrasound observations during stent implantation. Circulation 1994;89:2026-34.
9. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
10. Pan M, Medina A, Romero M, Suárez de Lezo J, Hernández E, Pavlovic DJ, et al. Peripheral stent recovery after failed intracoronary delivery. Cathet Cardiovasc Diagn 1992;27:230-3.
11. Medina A, Melian F, Suárez de Lezo J, Pan M, Romero M, Hernández E, et al. Effectiveness of coronary stenting for the treatment of chronic total occlusion in angina pectoris. Am J Cardiol 1994;73:1222-4.
12. Pan M, Medina A, Suárez de Lezo J, Romero M, Melián F, Pavlovic DJ, et al. Follow-up patency of side branches covered by an intracoronary Palmaz-Schatz stent. Am Heart J 1995;129:436-40.
13. Carrozza JP, Kuntz RE, Levine MJ Pomerantz RM, Fishman RF, Mansour M, et al. Angiographie and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-37.
14. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R, et al. Intracoronary stenting without couroarin: one month results of a French multicenter study. Cathet Cardiovasc Diagn 1995;35:1-8.
15. Hirsh J. Low molecular weight heparin. Thromb Haemost 1993;70:204-7.
16. Barrowcliffe TW, Johnson EA, Thomas DP. Low molecular weight heparin. Chichester (UK): J Wiley & Sons, 1992.
17. Kakkar V. Prevention of venous thrombosis and pulmonary embolism. Am J Cardiol 1990;65:50C-4C.
18. Gurfinkel EP, Manos EJ, Mejaíl RI, Cerda MA, Duroto EA, Garcia CN, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-8.
19. Bendetowicz AV, Kai H, Knebel R, Caplain H, Hemker HC, Lindhout T, et al. The effect of subcutaneous injection of unfractionated and low molecular and low molecular weight heparin on thrombin generation in platelet rich plasma: a study in human volunteers. Thromb Haemost 1994;72:705-12.
20. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazin F, Salvatori VA, et al. Aspirin and dipyridamol in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
21. Sanz G, Pajaron A, Alegria E, Coello I, Cardona M, Fournier JA, et al., and the Grapo Español para el Seguimiento del Injerto Coronario (GESIC). Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Circulation 1990;82:765-73.
22. Fuster V, Jang IK. Role of platelet-inhibitor agents in coronary artery disease. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders, 1994:3-22.
23. Hardisty RM, Powling MJ, Nokes TJC. The action of ticlopidine on human platelets: studies on aggregation, secretion, calcium mobilization and membrane glycoproteins. Thromb Haemost 1990;64:150-6.
24. Fitzgerald GA. Drug therapy: dipyridamole. N Engl J Med 1987;316: 1247-57.
25. Ueda Y, Nanto S, Komamura K, Kodama K. Neontimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994;23:341-6.
26. Andrew JC, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-405.
27. Fernández Avilés F, Alonso JJ, Duran JM, Gimeno F, Muñoz JC, Fuente L, et al. Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen. J Am Coll Cardiol 1996;27:22-9.
28. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-22.
29. Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.